Concord Biotech
About Us
Vision & Mission
Global Presence
Evolution
Leadership
R & D
API
Biotechnology
Chemical
Formulation
Formulation Development
Facilities
API
Formulation
Accreditation
API
Formulation
Products
API
Products
Contract Research & Manufacturing
Formulation
Regulated Markets
Emerging Markets
Contract Research & Manufacturing
India Formulation
Critical Care
Nephrology
Investors
Disclosures under Regulation 46 of LODR
CSR
Career
API Unit 1
Formulation Unit 2
API Unit 3
Sales & Marketing / Corporate
News
More+
Contact Us
Blog
ANNUAL REPORT INVESTORS
Financial Year
Select Financial Year
2024-25
2023-24
2022-23
2021-22
2020-21
Quarter
Select Quarter
ANY
Q1
Q2
Q3
Q4
Apply
Quarterly Results
Notice of 32nd Annual General Meeting
Annual Report – FY 2022-23
Annual Report – FY 2022-23 (High Resolution)
Annual Report – FY 2022-23 (Web Version)
Disclosures Under Regulation 14 of SEBI ESOP Regulations